Stay updated on Neo-adjuvant Pembrolizumab in Stage IV Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Neo-adjuvant Pembrolizumab in Stage IV Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neo-adjuvant Pembrolizumab in Stage IV Ovarian Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page now includes a 'No longer looking for participants' notice and new help sections, including 'How to Read a Study Record', 'Common Questions', 'How to Join a Study', and the 'Intervention/Treatment' topic. The revision tag was updated from v3.5.5 to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-15T07:58:22.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The page now shows revision v3.5.5, replacing the previous v3.5.4. This reflects an internal update to the site without altering study data or visible content.
    Difference
    0.1%
    Check dated 2026-06-08T03:44:38.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The page revision tag was updated to v3.5.4, replacing the previous v3.5.3 to reflect a new version of the study record.
    Difference
    0.1%
    Check dated 2026-05-17T09:37:53.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    The page footer version indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a site/software update rather than a change to the clinical study information.
    Difference
    0.1%
    Check dated 2026-04-25T18:40:40.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Revision: v3.5.2 updated from v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-18T13:34:55.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    No substantive changes detected in the study record; the study details and eligibility criteria appear unchanged.
    Difference
    0.1%
    Check dated 2026-04-11T10:40:56.000Z thumbnail image

Stay in the know with updates to Neo-adjuvant Pembrolizumab in Stage IV Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neo-adjuvant Pembrolizumab in Stage IV Ovarian Cancer Clinical Trial page.